Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brodalumab in Pustular Psoriasis and Psoriatic Erythroderma
NCT01782937Phase 3Completed
- Sponsor
- Kyowa Kirin
- Start
- Feb 2013
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
A Phase 3 trial of brodalumab in pustular psoriasis, erythrodermic psoriasis, sponsored by Kyowa Kirin. Started Feb 2013; status: completed.
02
Drugs
brodalumab
03
Conditions
pustular psoriasiserythrodermic psoriasis
Beyond the preview
Go deeper on NCT01782937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01782937.